参考文献/References:
[1] Postolache TT, Wadhawan A, Can A, et al. Inflammation in traumatic brain injury [J]. J Alzheimers Dis, 2020, 74(1):1-28.
[2] Lorente L, Martín MM, Pérez-Cejas A, et al. Traumatic brain injury patients mortality and serum total antioxidant capacity [J]. Brain Sci, 2020, 10(2): 2-7.
[3] Gayet-Ageron A, Prieto-Merino D, Ker K, et al. Effect of treatment delay on the effectiveness and safety of antifibri-nolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40138 bleeding patients[J]. Lancet, 2018, 391: 125-132.
[4] Hunt BJ. The current place of tranexamic acid in the man-agement of bleeding [J]. Anaesthesia, 2015, 70: 50-53.
[5] CRASH-3 trial collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbi-dities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebocontrolled trial [J]. Lancet, 2019, 394: 1713-1723.
[6] Epstein DS, Mitra B, Cameron PA, et al. Acute traumaticcoagulopathy in the setting of isolated traumatic brain injury: definition, incidence and outcomes [J]. Br J Neuro-surg, 2015, 29(1): 118-122.
[7] Medcalf RL. Fibrinolysis: from blood to the brain [J]. ThrombHaemost, 2017, 15(11): 2089-2098.
[8] Lecker I, Wang DS, Romaschin AD, et al. Tranexamic acid concentrations associated with human seizures inhibit gly-cine receptors [J]. J Clin Invest, 2012, 122(12): 4654-4666.
[9] Beno S, Ackery AD, Callum J, et al. Tranexamic acid inpediatric trauma: why not [J]? Crit Care, 2014, 18: 313-313.
[10] McCormack PL. Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis [J]. Drugs, 2012, 72(5): 585-617.
[11] CRASH-2 Collaborators, Shakur H, Roberts I, et al. Effects of tranexamic acid Page 10 of 18 Wellcome Open Research 2018, 3:86 Last updated: 26 SEP 2018 on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial [J]. Lancet, 2010, 376: 23-32.
[12] CRASH-2 Collaborators, Roberts I, Shakur H, et al. Theimportance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial [J]. Lancet, 2011,377(9771): 1096-1101.
[13] Mousavinejad M, Mozafari J, Ilkhchi RB, et al. Intravenous tranexamic acid for brain contusion with intraparenchymal hemorrhage: randomized, double-blind, placebo-controlledtrial [J]. Rev Recent Clin Trials, 2020, 15(1): 70-75.
[14] CRASH-- Intracranial Bleeding Mechanistic Study Colla-borators. Tranexamic acid in traumatic brain injury: an explanatory study nested within the CRASH-3 trial [J]. Eur J Trauma Emerg Surg. Epub 2020 Feb 19. doi: 10.1007/s00068-020-01316-1.
[15] Hijazi N, Abu Fanne R, Abramovitch R, et al. Endogenous plasminogen activators mediate progressive intracranial hemorrhage after traumatic brain injury [J]. Blood, 2015,125: 2558-2567.
[16] Medcalf RL. The traumatic side of fibrinolysis [J]. Blood,2015, 125: 2457-2458.
[17] Roberts I, Shakur H, Coats T, et al. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients [J]. Health Technol Assess, 2013, 17(10): 1-79.
[18] CRASH-trial collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbi-dities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial [J].Lancet, 2019, 394(10210): 1713-1723.
[19] Fakharian E, Abedzadeh-Kalahroudi M, Atoof F. Effect of tranexamic acid on prevention of hemorrhagic mass growth in patients with traumatic brain injury [J]. World Neurosurg,2018, 109(1): e748-e753.
[20] Jokar A, Ahmadi K, Salehi T, et al. The effect of tranexamic acid in traumatic brain injury: a randomized controlled trial[J]. Chin J Traumatol, 2017, 20(1): 49-51.
[21] Chakroun-Walha O, Samet A, Jerbi M, et al. Benefits of the tranexamic acid in head trauma with no extracranial bleeding: a prospective follow-up of 180 patients [J]. Eur J Trauma Emerg Surg, 2019, 45(4): 719-726.
[22] Weng S, Wang W, Wei Q, et al. Effect of tranexamic acid in patients with traumatic brain injury: a systematic review and meta-analysis [J]. World Neurosurg, 2019, 123(3): 128-135.
[23] Lei J, Gao GY, Jiang JY. Is management of acute traumatic brain injury effective: a literature review of published Cochrane Systematic Reviews [J]. Chin J Traumatol, 2012,15(1): 17-22.
[24] 倪燕青，杨静红，顾昀来，等. 氨甲环酸在颅脑创伤院前急救中的应用[J]. 中华创伤杂志，2018，34（4）：293-298.
[25] 陈 晨，白 磊，霍国进，等. 氨甲环酸预防创伤性脑损伤患者的颅内血肿增大的疗效研究[J]. 卒中与神经疾病，2018，25（6）：722-725.
[26] 熊海兵，徐 睿，程 强，等. 颅脑外伤患者使用氨甲环酸时间窗的研究[J]. 检验医学与临床，2017，14：2821-2823.
[27] 王 磊，周开国，李建忠. 院前使用血凝酶或氨甲环酸对颅脑损伤患者止血效果及预后影响的研究[J]. 中国药事，2020，34（2）：246-252.
相似文献/References:
[1]张善纲 综述.现代战争中颅脑损伤的特点及功能康复[J].中国临床神经外科杂志,2015,(11):701.[doi:10.13798/j.issn.1009-153X.2015.11.021]
[2]钟秀均 黄书岚.复方醒脑液治疗颅脑损伤后综合征的临床观察[J].中国临床神经外科杂志,2016,(05):278.[doi:10.13798/j.issn.1009-153X.2016.05.007]
ZHONG Xiu-jun,HUANG Shu-lan..Clinical observation on treatment of compound decoction for cerebral prorection for post-traumatic brain syndrome[J].,2016,(06):278.[doi:10.13798/j.issn.1009-153X.2016.05.007]
[3]李国亮 邸 方 杨亚东.香芹酚通过抑制脑水肿与氧化应激反应保护大鼠
颅脑损伤[J].中国临床神经外科杂志,2016,(05):283.[doi:10.13798/j.issn.1009-153X.2016.05.009]
LI Guo-liang,DI Fang,YANG Ya-dong..Carvacrol protects against traumatic brain injury in rats through suppressing the brain edma and oxidative stress[J].,2016,(06):283.[doi:10.13798/j.issn.1009-153X.2016.05.009]
[4]罗心凯 陈治标 陈谦学.免缝胶原海绵人工硬脑膜在颅脑损伤大骨瓣减压术中的应用[J].中国临床神经外科杂志,2016,(06):357.[doi:10.13798/j.issn.1009-153X.2016.06.012]
LUO Xin-kai,CHEN Zhi-biao,CHEN Qian-xue..Application of collagen sponge artificial dura without suturing to big bone flap decompression after traumatic brain injury[J].,2016,(06):357.[doi:10.13798/j.issn.1009-153X.2016.06.012]
[5]贺瑛福 肖宗宇 马进海 许常林 裴 杰 袁 岗 张广华 巨 虎.高海拔地区重型颅脑损伤血清FSH、LH、PRL的变化[J].中国临床神经外科杂志,2016,(06):359.[doi:10.13798/j.issn.1009-153X.2016.06.013]
HE Ying-fu,XIAO Zong-yu,MA Jin-hai,et al.Changes in serum FSH, LH and PRL levels in the patients with severe traumatic brain injury in plateau[J].,2016,(06):359.[doi:10.13798/j.issn.1009-153X.2016.06.013]
[6]满明昊 李立宏 杨彦龙 李 敏 郭少春.颅脑损伤术后细胞免疫指标变化及脾多肽对其影响[J].中国临床神经外科杂志,2016,(06):362.[doi:10.13798/j.issn.1009-153X.2016.06.014]
MAN Ming-hao,LI Li-hong,YANG Yan-yong,et al.Changes in peripheral cells immunity after operation and effect of spleen polypeptide on them in patients with traumatic brain injury[J].,2016,(06):362.[doi:10.13798/j.issn.1009-153X.2016.06.014]
[7]程 勇 秦加新 戢翰升 李 刚 聂劲林 李 强.颅脑损伤术中急性脑膨出的相关因素分析[J].中国临床神经外科杂志,2016,(06):374.[doi:10.13798/j.issn.1009-153X.2016.06.019]
[8]张一帆 综述 张国来 审校.弥漫性轴索损伤影像学诊断的研究进展[J].中国临床神经外科杂志,2016,(07):442.[doi:10.13798/j.issn.1009-153X.2016.07.020]
[9]陈吉钢 张丹枫 魏嘉良 邹 伟 侯立军.创伤性眶上裂综合征的治疗陈吉钢[J].中国临床神经外科杂志,2016,(04):200.[doi:10.13798/j.issn.1009-153X.2016.04.003]
CHEN Ji-gang,ZHANG Dan-feng,WEI Jiang-liang,et al.Management of traumatic superior orbital fissure syndrome (report of 22 cases)[J].,2016,(06):200.[doi:10.13798/j.issn.1009-153X.2016.04.003]
[10]肖连福 黄瑞宏 陈昌勇.外伤性颅内静脉窦血栓形成1例[J].中国临床神经外科杂志,2016,(04):256.[doi:10.13798/j.issn.1009-153X.2016.04.024]